Dow Up0.00% Nasdaq Up0.09%

Genetic Technologies Limited (GENE)

0.39 Down 0.04(10.10%) Nov 28, 12:59PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):3.0
Mean Recommendation (last week):3.0

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:2.50
Median Target:2.50
High Target:2.50
Low Target:2.50
No. of Brokers:1

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Feb 13, 2014Ladenburg ThalmannUpgradeNeutralBuy
May 3, 2013Ladenburg ThalmannUpgradeSellNeutral
Nov 16, 2012Ladenburg ThalmannDowngradeBuySell
Nov 30, 2011Ladenburg ThalmannInitiated Buy
Jun 2, 2004First AlbanyInitiated Strong Buy
Apr 15, 2004Legg MasonInitiated Buy
Jan 27, 2004FulcrumInitiated Buy
Jun 18, 2001Friedman BillingsUpgradeMkt PerformAccumulate
May 25, 2001Friedman BillingsDowngradeAccumulateMkt Perform
May 23, 2001Ladenburg ThalmannInitiated NT/LT Strong Buy

More Upgrades & Downgrades for GENE

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy0011

Data provided by Thomson/First Call

Currency in USD.